EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Rapid and highly sensitive immunoassay using an ultra-thin immuno-wall microfluidic device with a sequential fluorescence signal increment method

Xiang Zhou, Toshihiro Kasama, Ryo Miyake

Analytical and Bioanalytical Chemistry · 2025

DOI: 10.1007/s00216-025-05916-x ↗

At a glance

Journal article in Analytical and Bioanalytical Chemistry, 2025. Written by Xiang Zhou and 2 co-authors. Institution: Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan. zhouxiang1211@g.ecc.u-tokyo.ac.jp. Major MEDLINE topics: COVID-19, SARS-CoV-2, Lab-On-A-Chip Devices, Spike Glycoprotein, Coronavirus. Cited 1 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: The University of Tokyo.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

We present a rapid and highly sensitive immunoassay platform based on an ultra-thin immuno-wall microfluidic device with an easy-to-perform sequential fluorescence signal increment method. The ultra-thin immuno-wall was fabricated using a special type of water-soluble photopolymer mixed with streptavidin via photolithography. During photolithography, the photopolymer formed a three-dimensional cross-linked structure, and streptavidin was immobilized in the cross-linked structure based on the click chemistry reaction. The immobilized streptavidin was used to immobilize biotin-conjugated antibodies on the cross-linked structure to capture biomarkers, forming immune complexes on the surface, known as an “immuno-wall.” A sequential fluorescence signal increment method utilizes two different fluorescence-labeled antibodies with high affinity that were incubated several cycles in the immuno-wall to enhance the fluorescence signal. Moreover, an ultra-thin immuno-wall was developed to reduce the nonspecific binding and increase the signal-to-noise ratio. To evaluate the performance of this immunoassay platform, the spike protein from the SARS-CoV-2 virus was selected as the target biomarker. This immunoassay platform exhibited a limit of detection of 0.01 ng/mL, and the detection time was 30 min, which is comparable to rapid antigen tests. This immunoassay platform demonstrates significant potential for early-phase disease diagnosis.

Subjects

MeSH terms (MEDLINE)

COVID-19SARS-CoV-2Lab-On-A-Chip DevicesSpike Glycoprotein, CoronavirusImmunoassayHumansLimit of DetectionStreptavidinFluorescenceAntibodies, ImmobilizedEquipment Design

Author keywords

Fluorescence immunoassayHigh sensitivityMicrofluidic devicePhotopolymerSARS-CoV-2 virus

Substances

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2StreptavidinAntibodies, Immobilized

Authors and institutions

  • Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan. zhouxiang1211@g.ecc.u-tokyo.ac.jp.
  • Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.

Funding

  • The University of Tokyo

Cite

APA

Zhou, X., Kasama, T., & Miyake, R. (2025). Rapid and highly sensitive immunoassay using an ultra-thin immuno-wall microfluidic device with a sequential fluorescence signal increment method. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-025-05916-x

Vancouver

Zhou X, Kasama T, Miyake R. Rapid and highly sensitive immunoassay using an ultra-thin immuno-wall microfluidic device with a sequential fluorescence signal increment method. Analytical and Bioanalytical Chemistry. 2025. doi:10.1007/s00216-025-05916-x

BibTeX
@article{Zhou2025,
  author = {Zhou, Xiang and Kasama, Toshihiro and Miyake, Ryo},
  title = {Rapid and highly sensitive immunoassay using an ultra-thin immuno-wall microfluidic device with a sequential fluorescence signal increment method},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2025},
  doi = {10.1007/s00216-025-05916-x}
}
Start for free →